Boothbay Fund Management’s Clorox CLX Stock Holding History

Boothbay Fund Management’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-44	Closed	-$849K	–	1886
2021 Q1	$849K	Buy	+44	New	+$8.47K	0.03%	685

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Boothbay Fund Management's CLX Position: Q3 2025 in Review

Boothbay Fund Management sold out of Clorox (CLX) in Q3 2025, closing a stake of 5,307 shares — an estimated $637K sold.

Boothbay Fund Management first reported a position in CLX in Q1 2016 and held it in 9 quarters. The position peaked at $1.83M in Q4 2023. 1,092 funds tracked by Wall St. Rank hold CLX as of Q3 2025.

Boothbay Fund Management reported no remaining Clorox position as of Q3 2025 after selling out during the quarter.
Boothbay Fund Management sold 5,307 Clorox shares in Q3 2025, an estimated $637K.
Boothbay Fund Management first reported a position in Clorox in Q1 2016 and held it in 9 quarters.
Boothbay Fund Management's Clorox position peaked at $1.83M in Q4 2023.
1,092 funds tracked by Wall St. Rank held Clorox as of Q3 2025.

Based on Boothbay Fund Management's 13F filing for Q3 2025, filed 14 Nov 2025.